84 related articles for article (PubMed ID: 32950589)
21. SUMOylation of PDPK1 Is required to maintain glycolysis-dependent CD4 T-cell homeostasis.
Sun F; Wang FX; Zhu H; Yue TT; Yang CL; Luo JH; Luo X; Zhou HF; Rong SJ; Lu WY; Zhou Q; Yang P; Xiong F; Liu YJ; Yan T; Liao YF; Zhang S; Wang CY
Cell Death Dis; 2022 Feb; 13(2):181. PubMed ID: 35210408
[TBL] [Abstract][Full Text] [Related]
22. Sumoylation of methionine adenosyltransferase alpha 1 promotes mitochondrial dysfunction in alcohol-associated liver disease.
Floris A; Chandla S; Lim Y; Barbier-Torres L; Seth K; Khangholi A; Li TWH; Robison A; Murray BJ; Lee S; Matsuda M; Murali R; Tomasi ML; Lu SC
Hepatology; 2023 Dec; ():. PubMed ID: 38100286
[TBL] [Abstract][Full Text] [Related]
23. Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation.
Sampaziotis F; de Brito MC; Madrigal P; Bertero A; Saeb-Parsy K; Soares FAC; Schrumpf E; Melum E; Karlsen TH; Bradley JA; Gelson WT; Davies S; Baker A; Kaser A; Alexander GJ; Hannan NRF; Vallier L
Nat Biotechnol; 2015 Aug; 33(8):845-852. PubMed ID: 26167629
[TBL] [Abstract][Full Text] [Related]
24. EASL Clinical Practice Guidelines on the management of cystic liver diseases.
;
J Hepatol; 2022 Oct; 77(4):1083-1108. PubMed ID: 35728731
[TBL] [Abstract][Full Text] [Related]
25. Identification of a Target Site for Covalent Inhibition of Protein Phosphohistidine Phosphatase 1.
Kim HJ; Jung H; Kim S; Seo JK; Kee JM
ACS Med Chem Lett; 2022 Dec; 13(12):1911-1915. PubMed ID: 36518699
[TBL] [Abstract][Full Text] [Related]
26. Liver Diseases: From Bench to Bedside.
Kanda T; Sasaki-Tanaka R; Terai S
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791491
[TBL] [Abstract][Full Text] [Related]
27. Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease.
Mahboobipour AA; Ala M; Safdari Lord J; Yaghoobi A
Orphanet J Rare Dis; 2024 Apr; 19(1):175. PubMed ID: 38671465
[TBL] [Abstract][Full Text] [Related]
28. Novel α-1,3-Glucosyltransferase Variants and Their Broad Clinical Polycystic Liver Disease Spectrum.
Boerrigter MM; Te Morsche RHM; Venselaar H; Pastoors N; Geerts AM; Hoorens A; Drenth JPH
Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628703
[TBL] [Abstract][Full Text] [Related]
29. Genetics, pathobiology and therapeutic opportunities of polycystic liver disease.
Olaizola P; Rodrigues PM; Caballero-Camino FJ; Izquierdo-Sanchez L; Aspichueta P; Bujanda L; Larusso NF; Drenth JPH; Perugorria MJ; Banales JM
Nat Rev Gastroenterol Hepatol; 2022 Sep; 19(9):585-604. PubMed ID: 35562534
[TBL] [Abstract][Full Text] [Related]
30. Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease.
Chen C; Wu H; Ye H; Tortajada A; Rodríguez-Perales S; Torres-Ruiz R; Vidal A; Peligros MI; Reissing J; Bruns T; Mohamed MR; Zheng K; Lujambio A; Iraburu MJ; Colyn L; Latasa MU; Arechederra M; Fernández-Barrena MG; Berasain C; Vaquero J; Bañares R; Nelson LJ; Trautwein C; Davis RJ; Martinez-Naves E; Nevzorova YA; Villanueva A; Avila MA; Cubero FJ
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008241
[TBL] [Abstract][Full Text] [Related]
31. CPAP enhances and maintains chronic inflammation in hepatocytes to promote hepatocarcinogenesis.
Chen RY; Yen CJ; Lin YJ; Wang JM; Tasi TF; Huang YC; Liu YW; Tsai HW; Lee MH; Hung LY
Cell Death Dis; 2021 Oct; 12(11):983. PubMed ID: 34686650
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of NAE-dependent protein hyper-NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease.
Lee-Law PY; Olaizola P; Caballero-Camino FJ; Izquierdo-Sanchez L; Rodrigues PM; Perugorria MJ; Azkargorta M; Elortza F; Martinez-Chantar ML; Aspichueta P; Marzioni M; Bujanda L; Drenth JPH; Banales JM
United European Gastroenterol J; 2021 Sep; 9(7):848-859. PubMed ID: 34310849
[TBL] [Abstract][Full Text] [Related]
33. Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets.
Santos-Laso A; Izquierdo-Sanchez L; Rodrigues PM; Huang BQ; Azkargorta M; Lapitz A; Munoz-Garrido P; Arbelaiz A; Caballero-Camino FJ; Fernández-Barrena MG; Jimenez-Agüero R; Argemi J; Aragon T; Elortza F; Marzioni M; Drenth JPH; LaRusso NF; Bujanda L; Perugorria MJ; Banales JM
Liver Int; 2020 Jul; 40(7):1670-1685. PubMed ID: 32378324
[TBL] [Abstract][Full Text] [Related]
34. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
Munoz-Garrido P; Marin JJ; Perugorria MJ; Urribarri AD; Erice O; Sáez E; Úriz M; Sarvide S; Portu A; Concepcion AR; Romero MR; Monte MJ; Santos-Laso Á; Hijona E; Jimenez-Agüero R; Marzioni M; Beuers U; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Drenth JP; Banales JM
J Hepatol; 2015 Oct; 63(4):952-61. PubMed ID: 26044126
[TBL] [Abstract][Full Text] [Related]
35. Bile Acids in Polycystic Liver Diseases: Triggers of Disease Progression and Potential Solution for Treatment.
Perugorria MJ; Labiano I; Esparza-Baquer A; Marzioni M; Marin JJ; Bujanda L; Banales JM
Dig Dis; 2017; 35(3):275-281. PubMed ID: 28249268
[TBL] [Abstract][Full Text] [Related]
36. Polycystic Liver Disease: Advances in Understanding and Treatment.
Masyuk TV; Masyuk AI; LaRusso NF
Annu Rev Pathol; 2022 Jan; 17():251-269. PubMed ID: 34724412
[TBL] [Abstract][Full Text] [Related]
37. Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models.
Lee-Law PY; Olaizola P; Caballero-Camino FJ; Izquierdo-Sanchez L; Rodrigues PM; Santos-Laso A; Azkargorta M; Elortza F; Martinez-Chantar ML; Perugorria MJ; Aspichueta P; Marzioni M; LaRusso NF; Bujanda L; Drenth JPH; Banales JM
J Hepatol; 2021 Feb; 74(2):394-406. PubMed ID: 32950589
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
